Novo Nordisk Promotional Symposium: Cardiovascular Protection Beyond Traditional Therapies: Managing Residual Risk with GLP-1 Ras.
This is a Novo Nordisk promotional session. Novo Nordisk has provided sponsorship to CliniLink Ltd to cover the cost of this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements except where indicated.
Deep Dive: CVRM Masterclass From Evidence to Implementation (Durham)
This meeting has been organised by CliniLink Ltd. The sponsors AbbVie, Ascensia Diabetes Care, Daiichi Sankyo, Lupin Healthcare, Novo Nordisk and Recordati, have provided financial support towards this event through exhibition stand sponsorship but have had no input into the meeting agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible for all content. Further information about the sponsorship can be found below.
Novo Nordisk Promotional Symposium: Cardiovascular Protection Beyond Traditional Therapies: Managing Residual Risk with GLP-1 Ras.
This is a Novo Nordisk promotional session. Novo Nordisk has provided sponsorship to CliniLink Ltd to cover the cost of this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements except where indicated.
See Sponsors below
£0.00
FACE TO FACE EVENT
THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY
Location: Ramside Hall, Carrville, Durham DH1 1TD
Event Agenda
| Time | Topic | Speaker |
|---|---|---|
| 09:30-09:50 | Registration, Networking and Coffee | |
| 09:50-10:00 | Introduction and welcome | Beverley Bostock and Professor Ahmet Fuat |
| 10:00-10:15 | Symposium | Reserved |
| 10:15-11:00 | Managing Heart Failure in Primary Care – beyond the QoF tick box | Professor Ahmet Fuat |
| 11:00-11:15 | Novo Nordisk Promotional Symposium: Cardiovascular Protection Beyond Traditional Therapies: Managing Residual Risk with GLP-1 Ras. This is a Novo Nordisk promotional session. Novo Nordisk has provided sponsorship to CliniLink Ltd to cover the cost of this meeting. Novo Nordisk has had no influence over the meeting agenda or arrangements except where indicated. | Novo Nordisk |
| 11:15-11:30 | Break | |
| 11:30-12:15 | CKD – managing the under recognised risk | William Burlace |
| 12:15-13:00 | Changing the Hypertension Paradigm - the West Yorkshire guidance | Emily Turner |
| 13:00-13.45 | Lunch | |
| 13.45-14:00 | Ascensia- Blood Glucose testing tools | Cathryn Bushby -Ascensia Diabetes Care |
| 14:00-14:05 | AbbVie- 5 min Promotional session | Adam Marshall |
| 14:15-15:15 | Implementing new NICE diabetes guidance in primary care | Beverley Bostock and Doha Ben-Hamed |
| 15:15-15-30 | Break | |
| 15:30-16:15 | Simplifying Lipid management in Primary Care | Prof Ahmet Fuat |
| 16:15-16:30 | Q&A – ask anything CVDRM related | Beverley Bostock and Professor Ahmet Fuat |
Learning Outcomes
By the end of the study day, participants will be able to:
-
Apply an integrated approach to CVRM risk assessment
-
Optimise RAAS inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, and lipid therapy
-
Manage complex multimorbidity, including HFrEF and CKD
-
Deliver prevention-focused, holistic reviews that improve long-term outcomes
Key Benefits
-
Practical application of NICE guidance
-
Clear decision-making frameworks
-
Improved confidence in CVRM prescribing
-
CPD certificate for revalidation
Additional Information
Face-to-face, CPD-accredited event.
Suitable for GPs, prescribing pharmacists, nurses, and primary care MDT members.
Meet the Speakers
Professor Ahmet Fuat
PhD, FRCGP, FRCP, FRCPE ,FESC, FPCCS, PGDiP CardiologyHonorary Professor, Durham University · GP & GPSI Cardiology (25+ years) · National Programme Director, CliniLink
A Darlington GP for 40 years and one of the UK’s leading voices in primary care cardiology. Professor Fuat established the UK’s first one-stop integrated heart failure clinic in 2002, earned his PhD researching heart failure diagnosis and natriuretic peptides, and has shaped NICE and ESC guidelines on CVD and heart failure — with his HF work featured in the BHF Blueprint for Heart Failure.
Fellow of the RCGP, RCP London, RCP Edinburgh, the ESC and the PCCS, he sits on the editorial boards of the British Journal of Cardiology and the Primary Care Cardiovascular Journal. He teaches because translating evidence into everyday practice is where patient care is won.
Beverley Bostock
RGN, MSc, MA, QNBev is an Advanced Nurse Practitioner in long-term conditions. She is currently President Elect of the Primary Care Cardiovascular Society. She has a special interest in cardiovascular disease (CVD), diabetes, heart failure, chronic kidney disease and lipid management along with common comorbidities such as metabolic liver disease, asthma and COPD. She is Editor in Chief of Practice Nurse Journal and has been a Queen’s Nurse since 2015.   In a previous role she developed and delivered accredited modules in cardiovascular disease, heart failure and diabetes in collaboration with the Open University. As well as holding an MA in Medical Ethics and Law and an MSc in Respiratory Care, Bev is currently completing an MSc in Diabetes Care with the University of Warwick. Bev has had an extensive range of articles published in various journals on the management of long-term conditions and is a regular speaker at national conferences.
Emily Turner
Emily Turner is the Lead GP Practice Pharmacist for a large practice in Leeds, with a special interest in cardio-renal disease. She has also held the role of West Yorkshire Clinical Lead for CVD Prevention, collaborating across the West Yorkshire Health and Care Partnership to enhance cardiovascular health outcomes. In this capacity, Emily has demonstrated extensive evidence in addressing and reducing health inequalities throughout the system. On a national level, Emily contributes as a member of the England CVDPREVENT Audit Clinical Panel, the National Atrial Fibrillation Expert Advisory Group, and as a Clinical Educator for the Royal Pharmaceutical Society. As an accomplished speaker, she offers valuable expertise and practical guidance to clinicians working in primary care.
Doha Ben-Hamed MPharm IP
MPharm IPDoha is a senior clinical pharmacist, independent prescriber, and senior lecturer in clinical pharmacy, working across the North East.  She has a specialist interest in cardiovascular, renal, and metabolic (CVRM) health within diabetes care and leads on medicines optimisation, clinical education, and system‑wide improvement. Doha is currently undertaking a postgraduate diploma in diabetes, further strengthening her expertise and her commitment to supporting multidisciplinary teams to deliver high‑quality, evidence‑based care for people living with diabetes.
William Burlace
I am clinical pharmacist with over 10 years experience in both community pharmacy and primary care, graduating from the University of Sunderland in 2013. Since completing my independent prescribing at the University of Salford in diabetes and running review clinics, I have specialised more specifically in CKD and general renal medicine. I am currently one of the lead pharmacists on a ICB wide CKD project looking to improve patients' outcomes and raise awareness and improve education in CKD. I am also a board member of the NENC Renal Network, working to solidify relations between secondary care, primary care and the pharmacy sector.
Working to improve patient outcomes, particularly in underserved communities, is a real passion of mine and the importance of close neighbourhood working and education plays a vital role in this.
Symposium Sponsor
Event Sponsors
This meeting has been organised by CliniLink Ltd. The sponsors AbbVie, Ascensia Diabetes Care, Daiichi Sankyo, Lupin Healthcare, Novo Nordisk and Recordati, have provided financial support towards this event through exhibition stand sponsorship but have had no input into the meeting agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible for all content. Further information about the sponsorship can be found below.
